|
|
|
Insider
Information: |
Labarre Michael J. |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
173,756 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$9,895,404 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
173,756 |
|
|
Total
Value |
$9,895,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-27.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Halozyme Therapeutics Inc |
HALO |
|
2024-09-18 |
173,756 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
121 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-03-01 |
4 |
AS |
$45.56 |
$839,364 |
D/D |
(18,324) |
122,800 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-04-01 |
4 |
AS |
$42.11 |
$1,221,037 |
D/D |
(28,689) |
122,800 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-04-01 |
4 |
OE |
$11.29 |
$323,899 |
D/D |
28,689 |
151,489 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-05-03 |
4 |
OE |
$11.29 |
$127,701 |
D/D |
11,311 |
134,111 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-07-01 |
4 |
OE |
$6.55 |
$264,063 |
D/D |
40,315 |
174,426 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-07-01 |
4 |
AS |
$45.70 |
$1,842,315 |
D/D |
(40,315) |
134,111 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-07-15 |
4 |
OE |
$6.55 |
$96,187 |
D/D |
14,685 |
148,796 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-10-01 |
4 |
OE |
$13.10 |
$385,795 |
D/D |
29,450 |
178,246 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-10-01 |
4 |
AS |
$39.93 |
$1,175,968 |
D/D |
(29,450) |
148,796 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2021-10-12 |
4 |
OE |
$13.10 |
$105,455 |
D/D |
8,050 |
156,846 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,133 |
164,979 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-10 |
4 |
D |
$34.94 |
$104,540 |
D/D |
(2,992) |
161,987 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,883 |
169,870 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-12 |
4 |
D |
$34.20 |
$93,195 |
D/D |
(2,725) |
167,145 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,771 |
172,916 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-14 |
4 |
D |
$33.64 |
$67,112 |
D/D |
(1,995) |
170,921 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-15 |
4 |
D |
$34.43 |
$40,283 |
D/D |
(1,170) |
173,137 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
|
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,386 |
174,307 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2022-11-15 |
4 |
AS |
$54.12 |
$541,263 |
D/D |
(10,000) |
163,137 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2022-12-13 |
4 |
AS |
$58.66 |
$586,675 |
D/D |
(10,000) |
153,137 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2023-01-17 |
4 |
AS |
$50.40 |
$504,590 |
D/D |
(10,000) |
143,137 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,133 |
151,270 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2023-02-10 |
4 |
D |
$48.92 |
$144,363 |
D/D |
(2,951) |
148,319 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2023-02-12 |
4 |
D |
$48.92 |
$133,307 |
D/D |
(2,725) |
153,477 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
|
2023-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,883 |
156,202 |
0 |
- |
|
121 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|